Chinese herbal medicines for the treatment of non-structural abnormal uterine bleeding in perimenopause: A systematic review and a meta-analysis

2018 ◽  
Vol 41 ◽  
pp. 252-260 ◽  
Author(s):  
Yujie Shang ◽  
Su Lu ◽  
Yun Chen ◽  
Xiumei Sun
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Herbal Medicines ◽  
Abnormal Uterine Bleeding ◽  
Uterine Bleeding ◽  
Chinese Herbal Medicines ◽  
Chinese Herbal

scholarly journals Protocol for Chinese Herbal Medicines Decoction Treatment of Angina Pectoris: a Systematic Review With Bayesian Network Meta-analysis

2021 ◽  
Author(s):  
Nan Li ◽  
Wentai Pang ◽  
Fengwen Yang ◽  
Bo Pang ◽  
Xinyao Jin ◽  
...  
Keyword(s):  
Systematic Review ◽  
Angina Pectoris ◽  
Herbal Medicine ◽  
Bayesian Network ◽  
Meta Analysis ◽  
Herbal Medicines ◽  
Cochrane Library ◽  
China National Knowledge Infrastructure ◽  
Chinese Herbal Medicines ◽  
Chinese Herbal

Abstract Background Angina pectoris (AP) is the primary symptom of coronary heart disease. Evidence has shown Chinese herbal medicines can bring benefits to patients suffering from AP. There are many kinds of herbal medicines. However, the difference between them has not been systematically analysed. It is uncertain which one is better. For comparison and ranking, a systematic review and network meta-analysis is needed. Methods We will search for the following 6 electronic databases: China Biological Medicine DataBase(CBM), China National Knowledge Infrastructure(CNKI), WanFang Database, PubMed, Embase and the Cochrane Library, from inception to May 2021. Randomized controlled trials, which aim to assess the efficacy and safety of 5 kinds of Chinese herbal medicine for AP will be included. The outcomes include reduction of AP, improvement of the electrocardiogram and adverse events. The study screening and data extraction will be presented by 2 researchers. The risk of bias will be assessed according to the Cochrane handbook. A Bayesian network meta-analysis will be performed to compare the efficacy of 5 Chinese herbal medicines. Surface under the cumulative rank curve value will be calculated to rank the efficacy of each herbal medicine.DiscussionOur protocol will be expected that the results of this study will provide evidence for Clinical Practice Guideline, clinical decisions, and development of proprietary Chinese medicines.Systematic review registrationPROSPERO registration number: CRD42019146185.

scholarly journals Does Adjuvant Treatment with Chinese Herbal Medicine to Antidiabetic Agents Have Additional Benefits in Patients with Type 2 Diabetes? A System Review and Meta-Analysis of Randomized Controlled Trials

2019 ◽  
Vol 2019 ◽  
pp. 1-14 ◽  
Author(s):  
De Jin ◽  
Jiaxing Tian ◽  
Qi Bao ◽  
Haiyu Zhang ◽  
Qiyou Ding ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Herbal Medicines ◽  
Controlled Trials ◽  
Antidiabetic Agents ◽  
Chinese Herbal Medicines ◽  
Randomized Controlled ◽  
Chinese Herbal

Introduction. In the present meta-analysis, we aimed to determine the effects of adjuvant treatment with Chinese herbal medicine (CHM) on antidiabetic agents having additional benefits in patients with type 2 diabetes. Methods. Randomized controlled trials were identified by searching the Cochrane Library, PUBMED, EMBASE, MEDLINE, the China National Knowledge Internet, Web of Science, Global Health, International Pharmaceutical Abstracts and the China biology medicine, Wanfang, and VIP databases. The intervention group received CHM as add-on treatment to antidiabetic agents therapy, and the control group received placebos in addition to antidiabetic agents or antidiabetic agents alone. We assessed pooled data, including weighted mean differences and 95% confidence intervals (CIs) using a random-effects model. Results. A total of 125 randomized controlled trials were included. 10 articles were included based on literature screening. All trials contrasted Chinese herbal medicines or Chinese herbal medicines + antidiabetic agents with placebo or antidiabetic agents + placebo and included a total of 2004 individuals with T2DM. All selected trials displayed evidence of high methodological quality and possessed a low risk of bias. Meta-analysis of the trials demonstrated that Chinese herbal medicines resulted in a more favorable blood glucose profile in contrast to placebo (P<0.05). The total efficacy rate differed significantly between the two groups (P<0.001). All ten included studies reported the occurrence of tolerable adverse effects. Conclusions. The results showed that in the intervention group, greater reductions were achieved for glucose control and body weight. The combined use of drugs improves the curative effect and has fewer adverse events and has additional benefits in patients with type 2 diabetes. This trial is registered with PROSPERO (CRD42018093867).

Sign in / Sign up

Export Citation Format

Share Document